MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
Establishment Labs Holdings DSO Ratio 2011-2026 | ESTA
Annual DSO Ratio Establishment Labs Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123 | 91 | 67.6 | 62.8 | 90.3 | 92.8 | 105 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 123 | 62.8 | 90.4 |
Quarterly DSO Ratio Establishment Labs Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 | 119 | 141 | - | 144 | 115 | 120 | - | 126 | 86.8 | 75 | - | 75.5 | 68.3 | 64.2 | - | 75.1 | 66.8 | 64.5 | - | 76.7 | 167 | 78.1 | - | 90.9 | 95.8 | 88.7 | - | 98.9 | 117 | 94.7 | - | 163 | 69.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 167 | 64.2 | 100 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
43.1 | $ 14.04 | 0.79 % | $ 2.11 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
ClearPoint Neuro
CLPT
|
46.1 | $ 15.16 | 4.19 % | $ 410 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
72 | $ 6.62 | 3.6 % | $ 475 M |  Israel |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
40.7 | $ 31.22 | -3.94 % | $ 1.44 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 4.59 | 2.68 % | $ 171 M |  France |
 |
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
85.8 | $ 3.42 | -3.39 % | $ 118 M | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
Electromed
ELMD
|
137 | $ 23.92 | 3.33 % | $ 202 M | USA |
 |
Bio-Rad Laboratories
BIO
|
66.9 | $ 269.65 | 0.29 % | $ 7.61 B | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
57.3 | $ 39.89 | 0.3 % | $ 5.94 K | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
65.7 | $ 73.48 | -2.22 % | $ 109 B | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
IRadimed Corporation
IRMD
|
56.8 | $ 100.5 | 1.42 % | $ 1.27 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
64.5 | $ 45.98 | -0.17 % | $ 1.43 B | USA |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
53.8 | $ 70.29 | 1.8 % | $ 3.83 B |  Britain |
 |
InMode Ltd.
INMD
|
5.36 | $ 13.96 | -0.14 % | $ 902 M | Israel |
 |
Pulmonx Corporation
LUNG
|
54.9 | $ 1.63 | 7.95 % | $ 63.8 M | USA |
 |
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
68.8 | $ 96.65 | -0.1 % | $ 124 B | USA |
 |
MiMedx Group
MDXG
|
57.3 | $ 5.28 | -1.31 % | $ 780 M | USA |
 |
Delcath Systems
DCTH
|
54.6 | $ 10.21 | 2.61 % | $ 291 M | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
0.704 | $ 0.75 | 16.11 % | $ 5.29 M | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
Insulet Corporation
PODD
|
40.7 | $ 248.12 | 1.17 % | $ 17.5 B | USA |
 |
Quanterix Corporation
QTRX
|
66.3 | $ 6.29 | 10.35 % | $ 236 M | USA |
 |
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | USA |